U 50488H

Drug Profile

U 50488H

Alternative Names: U 50488

Latest Information Update: 01 Mar 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pharmacia Corporation
  • Developer Nonindustrial source; Pharmacia Corporation
  • Class Antiarrhythmics; Antiepileptic drugs; Antirheumatics; Antiulcers; Neuroprotectants; Opioid analgesics
  • Mechanism of Action Opioid kappa receptor agonists; Potassium channel antagonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Anxiety disorders; Arrhythmias; Pain; Peptic ulcer; Rheumatoid arthritis

Most Recent Events

  • 01 Mar 2004 Discontinued - Preclinical for Anxiety disorders (unspecified route)
  • 01 Mar 2004 Discontinued - Preclinical for Arrhythmias in Australia (unspecified route)
  • 01 Mar 2004 Discontinued - Preclinical for Arrhythmias in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top